KEGG   ORTHOLOGY: K05208
Entry
K05208                      KO                                     

Name
GRIN1
Definition
glutamate receptor ionotropic, NMDA 1
Pathway
ko04014  Ras signaling pathway
ko04015  Rap1 signaling pathway
ko04020  Calcium signaling pathway
ko04024  cAMP signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko04713  Circadian entrainment
ko04720  Long-term potentiation
ko04724  Glutamatergic synapse
ko05010  Alzheimer disease
ko05014  Amyotrophic lateral sclerosis
ko05016  Huntington disease
ko05017  Spinocerebellar ataxia
ko05020  Prion disease
ko05022  Pathways of neurodegeneration - multiple diseases
ko05030  Cocaine addiction
ko05031  Amphetamine addiction
ko05033  Nicotine addiction
ko05034  Alcoholism
Disease
H00773  Autosomal dominant mental retardation
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04014 Ras signaling pathway
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
   04015 Rap1 signaling pathway
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
   04020 Calcium signaling pathway
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
   04024 cAMP signaling pathway
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
 09150 Organismal Systems
  09156 Nervous system
   04724 Glutamatergic synapse
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
   04720 Long-term potentiation
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
  09159 Environmental adaptation
   04713 Circadian entrainment
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
 09160 Human Diseases
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
   05014 Amyotrophic lateral sclerosis
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
   05016 Huntington disease
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
   05017 Spinocerebellar ataxia
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
   05020 Prion disease
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
   05022 Pathways of neurodegeneration - multiple diseases
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
  09165 Substance dependence
   05030 Cocaine addiction
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
   05031 Amphetamine addiction
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
   05033 Nicotine addiction
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
   05034 Alcoholism
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04040 Ion channels
    K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
Ion channels [BR:ko04040]
 Ligand-gated channels
  Glutamate (ionotropic)
   K05208  GRIN1; glutamate receptor ionotropic, NMDA 1
Other DBs
GO: 0004972 0005234
TC: 1.A.10.1.6 1.A.10.1.12
Genes
HSA: 2902(GRIN1)
PTR: 465176(GRIN1)
PPS: 100987673(GRIN1)
GGO: 101146203(GRIN1)
PON: 100435177(GRIN1)
NLE: 100607572(GRIN1)
MCC: 574380(GRIN1)
MCF: 102115033(GRIN1)
CSAB: 103239575(GRIN1)
RRO: 104669771(GRIN1)
RBB: 108542864(GRIN1)
CJC: 100413857(GRIN1)
SBQ: 101054145(GRIN1)
MMU: 14810(Grin1)
MCAL: 110285719(Grin1)
MPAH: 110319261(Grin1)
RNO: 24408(Grin1)
MUN: 110556997(Grin1)
CGE: 100770880(Grin1)
NGI: 103732604(Grin1)
HGL: 101720185(Grin1)
CCAN: 109687368
TUP: 102469683(GRIN1)
CFA: 494007(GRIN1)
VVP: 112911422(GRIN1)
AML: 100465687(GRIN1)
UMR: 103675310(GRIN1)
ORO: 101368224(GRIN1)
FCA: 101082021(GRIN1)
PTG: 102949242(GRIN1)
PPAD: 109260229(GRIN1)
AJU: 106989187(GRIN1)
BTA: 100336579(GRIN1)
BOM: 102276953(GRIN1)
BBUB: 102403040(GRIN1)
CHX: 102181789(GRIN1)
OAS: 443281(GRIN1)
SSC: 397440(GRIN1)
CFR: 102506181(GRIN1)
CDK: 105106183(GRIN1)
BACU: 103001022(GRIN1)
LVE: 103085162(GRIN1)
OOR: 101278622(GRIN1)
DLE: 111176991(GRIN1)
PCAD: 102987558(GRIN1)
ECB: 100059861(GRIN1)
EPZ: 103563588(GRIN1)
EAI: 106822778(GRIN1)
MYB: 102240692(GRIN1)
MYD: 102751770(GRIN1)
MNA: 107536149(GRIN1)
HAI: 109382502(GRIN1)
DRO: 112306277(GRIN1)
PALE: 102894415(GRIN1)
RAY: 107503090(GRIN1)
MJV: 108388298(GRIN1)
LAV: 100663779(GRIN1)
TMU: 101349517
MDO: 100023485(GRIN1)
SHR: 100922600(GRIN1)
PCW: 110205260(GRIN1)
OAA: 100082705(GRIN1)
GGA: 404296(GRIN1)
MGP: 100548054(GRIN1)
CJO: 107321672(GRIN1)
NMEL: 110406928(GRIN1)
APLA: 101789524(GRIN1)
ACYG: 106037054(GRIN1)
TGU: 751779(GRIN1)
LSR: 110472204(GRIN1)
SCAN: 103819186(GRIN1)
GFR: 102040955(GRIN1)
FAB: 101818610(GRIN1)
PHI: 102108893(GRIN1)
PMAJ: 107212141(GRIN1)
CCAE: 111936905(GRIN1)
CCW: 104688213(GRIN1)
ETL: 114064163(GRIN1)
FPG: 101913185(GRIN1)
FCH: 102047364(GRIN1)
CLV: 102098434(GRIN1)
EGZ: 104123999(GRIN1)
NNI: 104022714(GRIN1)
ACUN: 113486654(GRIN1)
PADL: 103918966(GRIN1)
AAM: 106487018(GRIN1)
ASN: 102370900(GRIN1)
AMJ: 102571725(GRIN1)
PSS: 102453445(GRIN1)
CMY: 102936758
CPIC: 101935314(GRIN1)
ACS: 100553024(grin1)
PVT: 110087451(GRIN1)
PBI: 103066289(GRIN1)
PMUR: 107302534(GRIN1)
TSR: 106541972(GRIN1)
PMUA: 114606269 114606384(GRIN1)
GJA: 107115159(GRIN1)
XLA: 108699855 397953(grin1.S)
XTR: 780048(grin1)
NPR: 108795933(GRIN1)
DRE: 100005675(grin1b) 767745(grin1a)
IPU: 108255876(grin1) 108278500
PHYP: 113535563 113536981(grin1)
LCO: 104936329(grin1)
NCC: 104966793(grin1)
BPEC: 110159188 110164000(grin1)
LCM: 102356038(GRIN1)
CMK: 103183009(grin1)
RTP: 109916194(grin1)
BFO: 118406774
CIN: 100186847
APLC: 110991116
SKO: 100370156
DME: Dmel_CG2902(Nmdar1)
DER: 6552207
DSE: 6613956
DSI: Dsimw501_GD19612(Dsim_GD19612)
DAN: 6500487
DSR: 110177232
DPE: 6591341
DMN: 108155503
DWI: 6641663
DNV: 108656036
DHE: 111603663
DVI: 6630672
MDE: 101898320
LCQ: 111680158
AALB: 109401442
AME: 406079(Nmdar1)
BIM: 100749947
BTER: 100644436
CCAL: 108627351
OBB: 114880618
SOC: 105201093
MPHA: 105832305
AEC: 105145837
ACEP: 105618959
PBAR: 105434122
VEM: 105570583
HST: 105182141
DQU: 106743549
CFO: 105258574
LHU: 105668471
PGC: 109857911
OBO: 105277859
PCF: 106791773
NVI: 100116847
CSOL: 105361136
MDL: 103580278
TCA: 658152
DPA: 109537645
ATD: 109594466
NVL: 108562030
BMOR: 101743090
BMAN: 114239380
PMAC: 106715411
PRAP: 110995370
HAW: 110377196
TNL: 113499389
PXY: 105389024
API: 100160524
DNX: 107162112
AGS: 114132519
RMD: 113549434
BTAB: 109031908
CLEC: 106661247
ZNE: 110837591
FCD: 110851005
PVM: 113812935
CSCU: 111639667
PTEP: 107441166
CEL: CELE_F07F6.6(nmr-1)
CBR: CBG02401(Cbr-nmr-1)
PCAN: 112565911
CRG: 105333721
MYI: 110451795
OBI: 106884058
LAK: 106178045
SHX: MS3_00804
ADF: 107354805
HMG: 100197210
SMIN: v1.2.020958.t1(symbB.v1.2.020958.t1)
 » show all
Reference
PMID:7685113
  Authors
Planells-Cases R, Sun W, Ferrer-Montiel AV, Montal M
  Title
Molecular cloning, functional expression, and pharmacological characterization of an N-methyl-D-aspartate receptor subunit from human brain.
  Journal
Proc Natl Acad Sci U S A 90:5057-61 (1993)
DOI:10.1073/pnas.90.11.5057
  Sequence
[hsa:2902]
LinkDB

KEGG   ORTHOLOGY: K05209
Entry
K05209                      KO                                     

Name
GRIN2A
Definition
glutamate receptor ionotropic, NMDA 2A
Pathway
ko04014  Ras signaling pathway
ko04015  Rap1 signaling pathway
ko04020  Calcium signaling pathway
ko04024  cAMP signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko04713  Circadian entrainment
ko04720  Long-term potentiation
ko04724  Glutamatergic synapse
ko04728  Dopaminergic synapse
ko05010  Alzheimer disease
ko05014  Amyotrophic lateral sclerosis
ko05017  Spinocerebellar ataxia
ko05020  Prion disease
ko05022  Pathways of neurodegeneration - multiple diseases
ko05030  Cocaine addiction
ko05031  Amphetamine addiction
ko05033  Nicotine addiction
ko05034  Alcoholism
ko05322  Systemic lupus erythematosus
Disease
H01514  Landau-Kleffner syndrome
H01827  Rolandic epilepsy, mental retardation, and speech dyspraxia
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04014 Ras signaling pathway
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
   04015 Rap1 signaling pathway
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
   04020 Calcium signaling pathway
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
   04024 cAMP signaling pathway
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
 09150 Organismal Systems
  09156 Nervous system
   04724 Glutamatergic synapse
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
   04728 Dopaminergic synapse
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
   04720 Long-term potentiation
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
  09159 Environmental adaptation
   04713 Circadian entrainment
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
 09160 Human Diseases
  09163 Immune disease
   05322 Systemic lupus erythematosus
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
   05014 Amyotrophic lateral sclerosis
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
   05017 Spinocerebellar ataxia
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
   05020 Prion disease
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
   05022 Pathways of neurodegeneration - multiple diseases
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
  09165 Substance dependence
   05030 Cocaine addiction
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
   05031 Amphetamine addiction
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
   05033 Nicotine addiction
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
   05034 Alcoholism
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04040 Ion channels
    K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
Ion channels [BR:ko04040]
 Ligand-gated channels
  Glutamate (ionotropic)
   K05209  GRIN2A; glutamate receptor ionotropic, NMDA 2A
Other DBs
GO: 0004972 0005234
TC: 1.A.10.1.6
Genes
HSA: 2903(GRIN2A)
PTR: 454396(GRIN2A)
PPS: 100977852(GRIN2A)
GGO: 101124569(GRIN2A)
PON: 100438553(GRIN2A)
NLE: 100584731(GRIN2A)
MCC: 100429880(GRIN2A)
MCF: 102123126(GRIN2A)
CSAB: 103228072(GRIN2A)
RRO: 104667722(GRIN2A)
RBB: 108541249(GRIN2A)
CJC: 100411569(GRIN2A)
SBQ: 101030380(GRIN2A)
MMU: 14811(Grin2a)
MCAL: 110311574(Grin2a)
MPAH: 110329701(Grin2a)
RNO: 24409(Grin2a)
NGI: 103731589(Grin2a)
HGL: 101716707(Grin2a)
OCU: 100337889(GRIN2A)
TUP: 102487925(GRIN2A)
CFA: 490012(GRIN2A)
VVP: 112923309(GRIN2A)
AML: 100469843(GRIN2A)
UMR: 103668590(GRIN2A)
UAH: 113270811(GRIN2A)
ORO: 101378928(GRIN2A)
ELK: 111156070
FCA: 101086110(GRIN2A)
PTG: 102969126(GRIN2A)
PPAD: 109278305(GRIN2A)
AJU: 106989347(GRIN2A)
BTA: 524212(GRIN2A)
BOM: 102283831(GRIN2A)
BIU: 109578088(GRIN2A)
BBUB: 102409649(GRIN2A)
CHX: 102189537(GRIN2A)
OAS: 101106989(GRIN2A)
SSC: 100736832(GRIN2A)
CFR: 102503788(GRIN2A)
CDK: 105089056(GRIN2A)
BACU: 103006151(GRIN2A)
LVE: 103091670(GRIN2A)
OOR: 101270526(GRIN2A)
DLE: 111163530(GRIN2A)
ECB: 100051329(GRIN2A)
EPZ: 103555146(GRIN2A)
EAI: 106836764
MYB: 102245838(GRIN2A)
MYD: 102771313(GRIN2A)
MNA: 107525462(GRIN2A)
HAI: 109387184(GRIN2A)
DRO: 112314932(GRIN2A)
PALE: 102898336(GRIN2A)
RAY: 107514651(GRIN2A)
TMU: 101353799
MDO: 100018255(GRIN2A)
SHR: 100920008(GRIN2A)
PCW: 110198344(GRIN2A)
OAA: 100074436(GRIN2A)
GGA: 427678(GRIN2A)
MGP: 100549076
CJO: 107320868(GRIN2A)
NMEL: 110405936(GRIN2A)
APLA: 101804769(GRIN2A)
ACYG: 106041218(GRIN2A)
TGU: 778440(GRIN2A)
LSR: 110474540(GRIN2A)
SCAN: 103817733(GRIN2A)
GFR: 102042287(GRIN2A)
FAB: 101819385(GRIN2A)
PHI: 102113741(GRIN2A)
PMAJ: 107211300(GRIN2A)
CCAE: 111935929(GRIN2A)
CCW: 104684701(GRIN2A)
ETL: 114058467(GRIN2A)
FPG: 101912351(GRIN2A)
FCH: 102048497(GRIN2A)
CLV: 102091639(GRIN2A)
EGZ: 104123229(GRIN2A)
NNI: 104023444(GRIN2A)
ACUN: 113485539(GRIN2A)
PADL: 103917561(GRIN2A)
AAM: 106482645(GRIN2A)
ASN: 102373605(GRIN2A)
AMJ: 102565271(GRIN2A)
PSS: 102459849(GRIN2A)
CMY: 102936101(GRIN2A)
CPIC: 101933703(GRIN2A)
ACS: 100557524(grin2a)
PVT: 110087033(GRIN2A)
PMUA: 114584457(GRIN2A)
GJA: 107111188(GRIN2A)
XLA: 100126660(nr2a) 100127346(grin2a.L)
XTR: 100489006(grin2a)
NPR: 108794358(GRIN2A)
DRE: 563297(grin2aa) 570493(grin2ab)
IPU: 108258284 108274125(grin2a)
PHYP: 113535803 113546901(grin2a)
AMEX: 103042056(grin2a)
EEE: 113572860(grin2a) 113580928
TRU: 101061712(grin2a)
LCO: 104917658(grin2a)
MZE: 101485837(grin2a)
ONL: 100534510(grin2a)
OLA: 101161811(grin2a)
XMA: 102237459(grin2a)
XCO: 114159872(grin2a)
PRET: 103468596(grin2a)
CVG: 107088100(grin2a)
NFU: 107376713(grin2a)
KMR: 108242983(grin2a)
ALIM: 106516529(grin2a)
AOCE: 111570022(grin2a)
CSEM: 103393273(grin2a)
POV: 109639537(grin2a)
LCF: 108881068(grin2a)
SDU: 111230208(grin2a)
SLAL: 111647519(grin2a)
HCQ: 109514843(grin2a)
BPEC: 110160561(grin2a)
MALB: 109958904(grin2a)
ELS: 105013466(grin2a)
SFM: 108926533 108937395(grin2a)
PKI: 111845544 111849101(grin2a)
BFO: 118429781
CIN: 101242030
 » show all
Reference
PMID:8428958
  Authors
Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M, et al.
  Title
Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.
  Journal
J Biol Chem 268:2836-43 (1993)
  Sequence
[rno:24409]
LinkDB

KEGG   ORTHOLOGY: K05210
Entry
K05210                      KO                                     

Name
GRIN2B
Definition
glutamate receptor ionotropic, NMDA 2B
Pathway
ko04014  Ras signaling pathway
ko04015  Rap1 signaling pathway
ko04024  cAMP signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko04713  Circadian entrainment
ko04720  Long-term potentiation
ko04724  Glutamatergic synapse
ko04728  Dopaminergic synapse
ko05010  Alzheimer disease
ko05014  Amyotrophic lateral sclerosis
ko05016  Huntington disease
ko05017  Spinocerebellar ataxia
ko05020  Prion disease
ko05022  Pathways of neurodegeneration - multiple diseases
ko05030  Cocaine addiction
ko05031  Amphetamine addiction
ko05033  Nicotine addiction
ko05034  Alcoholism
ko05322  Systemic lupus erythematosus
Disease
H00606  Early infantile epileptic encephalopathy
H00773  Autosomal dominant mental retardation
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04014 Ras signaling pathway
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
   04015 Rap1 signaling pathway
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
   04024 cAMP signaling pathway
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
 09150 Organismal Systems
  09156 Nervous system
   04724 Glutamatergic synapse
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
   04728 Dopaminergic synapse
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
   04720 Long-term potentiation
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
  09159 Environmental adaptation
   04713 Circadian entrainment
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
 09160 Human Diseases
  09163 Immune disease
   05322 Systemic lupus erythematosus
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
   05014 Amyotrophic lateral sclerosis
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
   05016 Huntington disease
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
   05017 Spinocerebellar ataxia
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
   05020 Prion disease
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
   05022 Pathways of neurodegeneration - multiple diseases
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
  09165 Substance dependence
   05030 Cocaine addiction
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
   05031 Amphetamine addiction
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
   05033 Nicotine addiction
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
   05034 Alcoholism
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04040 Ion channels
    K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
Ion channels [BR:ko04040]
 Ligand-gated channels
  Glutamate (ionotropic)
   K05210  GRIN2B; glutamate receptor ionotropic, NMDA 2B
Other DBs
GO: 0004972 0005234
TC: 1.A.10.1.6
Genes
HSA: 2904(GRIN2B)
PTR: 473373(GRIN2B)
PPS: 100974219(GRIN2B)
GGO: 101127573(GRIN2B)
PON: 100458706(GRIN2B)
NLE: 100594244(GRIN2B)
MCC: 698571(GRIN2B)
MCF: 101866879(GRIN2B)
CSAB: 103218664(GRIN2B)
RRO: 104679865(GRIN2B)
RBB: 108530279(GRIN2B)
CJC: 100415252(GRIN2B)
SBQ: 101036659(GRIN2B)
MMU: 14812(Grin2b)
MCAL: 110296148(Grin2b)
MPAH: 110316284(Grin2b)
RNO: 24410(Grin2b)
MUN: 110546904
CGE: 118239276(Grin2b)
NGI: 103737584(Grin2b)
HGL: 101723091(Grin2b)
CCAN: 109679370(Grin2b)
OCU: 100353266(GRIN2B)
TUP: 102487806(GRIN2B)
CFA: 494009(GRIN2B)
VVP: 112917264(GRIN2B)
AML: 100466153(GRIN2B)
UMR: 103677769(GRIN2B)
UAH: 113257861(GRIN2B)
ORO: 101365544(GRIN2B)
ELK: 111142166
FCA: 101094356(GRIN2B)
PTG: 102962401(GRIN2B)
PPAD: 109268638(GRIN2B)
AJU: 106965657(GRIN2B)
BTA: 537804(GRIN2B)
BOM: 102273574(GRIN2B)
BIU: 109559635(GRIN2B)
BBUB: 102412577(GRIN2B)
CHX: 108636054(GRIN2B)
OAS: 101118179(GRIN2B)
SSC: 100626022(GRIN2B)
CFR: 102517500(GRIN2B)
CDK: 105096536(GRIN2B)
BACU: 102999259(GRIN2B)
LVE: 103082207(GRIN2B)
OOR: 101285554(GRIN2B)
DLE: 111176787(GRIN2B)
PCAD: 102992015(GRIN2B)
ECB: 100063746(GRIN2B)
EPZ: 103549904(GRIN2B)
EAI: 106826757(GRIN2B)
MYB: 102249136(GRIN2B)
MYD: 102759239(GRIN2B)
MNA: 107525331(GRIN2B)
HAI: 109383120(GRIN2B)
DRO: 112318404(GRIN2B)
PALE: 102882716(GRIN2B)
RAY: 107508606(GRIN2B)
MJV: 108406616(GRIN2B)
LAV: 100660738(GRIN2B)
TMU: 101340402
MDO: 100017355(GRIN2B)
SHR: 100926323(GRIN2B)
PCW: 110218783(GRIN2B)
OAA: 100090612(GRIN2B)
GGA: 417965(GRIN2B)
MGP: 100545618(GRIN2B)
CJO: 107313627(GRIN2B)
NMEL: 110388345(GRIN2B)
APLA: 101801248(GRIN2B)
ACYG: 106046004(GRIN2B)
TGU: 751956(GRIN2B)
LSR: 110483192(GRIN2B)
SCAN: 103813324(GRIN2B)
GFR: 102042847(GRIN2B)
FAB: 101815118(GRIN2B)
PHI: 102112194(GRIN2B)
PMAJ: 107204929(GRIN2B)
CCAE: 111934106(GRIN2B)
CCW: 104696379(GRIN2B)
ETL: 114062445(GRIN2B)
FPG: 101912862(GRIN2B)
FCH: 102049246(GRIN2B)
CLV: 102083625
EGZ: 104134355(GRIN2B)
NNI: 104021666(GRIN2B)
ACUN: 113475853(GRIN2B)
PADL: 103915379(GRIN2B)
AAM: 106488416(GRIN2B)
ASN: 102380409(GRIN2B)
AMJ: 102574919(GRIN2B)
PSS: 102444623(GRIN2B)
CMY: 102940243(GRIN2B)
CPIC: 101953859(GRIN2B)
ACS: 100566053(grin2b)
PVT: 110076081(GRIN2B)
PBI: 103053465
PMUR: 107288989(GRIN2B)
PMUA: 114605053(GRIN2B)
GJA: 107120667(GRIN2B)
XLA: 100126610(nr2b) 100127347(grin2b.L)
XTR: 100490580(grin2b)
NPR: 108794295(GRIN2B)
DRE: 100334883 110438919 559976(grin2bb)
AMEX: 103024987 103041816(grin2b)
TRU: 101075714 101078007(grin2b)
LCO: 104934370(grin2b) 104938869
NCC: 104944974(grin2b) 104953995
MZE: 101465427 101475595(grin2b)
ONL: 100694586(grin2b) 100709169
OLA: 101163953 101173552(grin2b)
XMA: 102219598(grin2b) 102235843
XCO: 114144992 114159802(grin2b)
PRET: 103468423(grin2b) 103468798
NFU: 107376282(grin2b) 107382198
KMR: 108236131(grin2b) 108241544
CSEM: 103383797 103393394(grin2b)
LCF: 108875923 108877576(grin2b)
SLAL: 111662450(grin2b) 111664480
HCQ: 109511231 109516452(grin2b)
BPEC: 110162372(grin2b) 110172639
MALB: 109958473 109974657(grin2b)
SASA: 106601208(grin2b)
ELS: 105005754 105006258(grin2b)
LCM: 102355334(GRIN2B)
CMK: 103191357(grin2b)
RTP: 109922578
SKO: 100329029(NMDAR2)
DME: Dmel_CG33513(Nmdar2)
DER: 6555638
DSE: 6616001
DSI: Dsimw501_GD16419(Dsim_GD16419)
DAN: 6504046
DSR: 110183499
DPE: 6596746
DMN: 108153626
DWI: 6652797
DAZ: 108619770
DNV: 108655627
DHE: 111604600
DVI: 6634736
MDE: 101889342
LCQ: 111678963
AAG: 5570106
AME: 412818
BIM: 100741138
BTER: 100643486
CCAL: 108629560
OBB: 114880494
SOC: 105205519
MPHA: 105837285
AEC: 105143243
PBAR: 105429018
VEM: 105569254
HST: 105185571
DQU: 106749514
CFO: 105254467
LHU: 105670141
PGC: 109852940
OBO: 105279967
PCF: 106793249
NVI: 100122774
CSOL: 105365543
TCA: 660406
DPA: 109542203
ATD: 109605562
BMOR: 101735975
BMAN: 114243591
PMAC: 106719082
PRAP: 110992162
HAW: 110370174
TNL: 113495765
PXY: 105382716
API: 100167874
DNX: 107167954
AGS: 114128867
RMD: 113558654
BTAB: 109036593
CLEC: 106666008
FCD: 110842844
PVM: 113829819
TUT: 107371665
DPTE: 113790752
CEL: CELE_T01C3.10(nmr-2)
CBR: CBG11585(Cbr-nmr-2)
CRG: 105347230
OBI: 106880576
LAK: 106164878
SHX: MS3_02890
EGL: EGR_04408
NVE: 5516903
 » show all
Reference
PMID:7524561
  Authors
Sullivan JM, Traynelis SF, Chen HS, Escobar W, Heinemann SF, Lipton SA
  Title
Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor.
  Journal
Neuron 13:929-36 (1994)
DOI:10.1016/0896-6273(94)90258-5
  Sequence
[rno:24410]
LinkDB

DBGET integrated database retrieval system